Related Experiment Video
Updated: May 24, 2026
09:03
Functional Imaging of Viral Transcription Factories Using 3D Fluorescence Microscopy
Published on: January 18, 2018
KSHV Rta Promoter Specification and Viral Reactivation
Jonathan Guito1, David M Lukac
1Graduate School of Biomedical Sciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey Newark, NJ, USA.
Frontiers in Microbiology
|February 21, 2012
Summary
Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation is controlled by the viral protein K-Rta. This review explores how K-Rta promoter binding influences KSHV reactivation, challenging previous models.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Herpesviruses establish lifelong latent infections, reactivating under specific conditions.
- Kaposi's sarcoma-associated herpesvirus (KSHV) latency is crucial for its persistence.
- Viral reactivation involves complex host-pathogen molecular interactions.
Purpose of the Study:
- To review the role of KSHV protein K-Rta in viral reactivation.
- To analyze K-Rta's promoter specificity in regulating KSHV lytic cycle progression.
- To discuss factors modulating K-Rta function and KSHV reactivation.
Main Methods:
- Literature review of KSHV K-Rta research.
- Analysis of molecular mechanisms controlling viral reactivation.
- Examination of host-viral protein interactions.
Main Results:
- K-Rta is essential and sufficient for KSHV reactivation initiation.
- K-Rta binds directly to viral DNA and recruits cellular proteins like RBP-Jk.
- KSHV reactivation is regulated post-K-Rta expression, indicating a non-bistable model.
Conclusions:
- K-Rta's promoter specification is a key regulatory step in KSHV reactivation.
- KSHV reactivation is a finely tuned process, not a simple on/off switch.
- Further research into K-Rta function can reveal new therapeutic targets.
More Related Videos
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...